US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 136.315
  • +1.715+1.27%
Close Nov 27 16:00 ET
  • 136.315
  • 0.0000.00%
Post 20:01 ET
8.15BMarket Cap-17292P/E (TTM)

Ascendis Pharma A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ascendis Pharma A/S Q3 2024 Earnings Date

Currency：EURNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
70.24M
57.83M
-12.40M
Miss Est.
+46.22%
+20.40%
-17.66%
EPS
-1.46
-1.72
-0.26
Miss Est.
+49.42%
+40.28%
-18.08%
Analyst Rating
Strong Buy

Nov 28, 2024

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.543M--
--2024/Q4-- / 97.532M--
Nov 14, 20242024/Q357.833M / 70.236M--
Sep 3, 20242024/Q235.998M / 84.468M--
May 2, 20242024/Q195.894M / 79.867M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.543M--
--2024/Q4-- / 97.532M--
Nov 14, 20242024/Q357.833M / 70.236M--
Sep 3, 20242024/Q235.998M / 84.468M--
May 2, 20242024/Q195.894M / 79.867M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14 16:59 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14 16:23 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 23 16:04 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 3 17:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 28, 2024

    Strong Buy

    • Buy

      93.33%

    • Hold

      6.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data